Skip to content

A Trial of HR021618 in Postsurgical Pain Management

A Phase Ⅱ, Multicenter, Randomized, Single-Blind, Placebo-Controlled, Evaluation of the Safety, Efficacy of HR021618 for Pain Management Following Orthopaedic Surgery

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04699175
Enrollment
108
Registered
2021-01-07
Start date
2020-12-17
Completion date
2021-08-08
Last updated
2021-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postsurgical Pain Management

Brief summary

The study is being conducted to evaluate the efficacy, safety of HR021618 and to explore the reasonable dosage of HR021618 for Pain Management after Orthopaedic surgery.

Interventions

Treatment group A:HR021618; high dose

DRUGPlacebo

Treatment group C: HR021618 blank preparation.

Sponsors

Jiangsu HengRui Medicine Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

HR021618 compared with placebo

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Able and willing to provide a written informed consent 2. Subjects requiring elective Orthopaedic surgery 3. Male or female 4. Meet the weight standard 5. Conform to the ASA Physical Status Classification Postoperative randomization criteria

Exclusion criteria

1、 Sufficient pain to require IVanalgesia assessed by NRS ranging 2、 No evidence of organ insufficiency, or any other abnormality, during or following surgery

Design outcomes

Primary

MeasureTime frameDescription
Usage of Morphine, Post Surgery0 hour to 24 hours after IP administrationChange in the amount of morphine use (in milligrams) by subjects in each treatment group for a 24 hour period post IP administration.

Secondary

MeasureTime frameDescription
Usage of Morphine, Post Surgery at other intervals0 hour to 48 hours after IP administrationChange in the amount of morphine use (in milligrams) by subjects in each treatment group for 0-48 hours after IP administration.
Pain intensity assessed using an 11-point NRS rangingBaseline till 48 hours post IP administration11-point NPRS ranging from a score of 0 to 10.
Pain relief assessed using an 5-point likert scaleBaseline till 48 hours post IP administration5-point likert scale from a score of 0 to 4.
Frequency of Doses of Rescue Analgesia Utilized Per Subject0 hour to 48 hours after IP administrationRescue analgesia was available to subjects with inadequately controlled pain upon request.
Proportion of subjects who received Rescue Analgesia0 hour to 48 hours after IP administrationProportion of rescue was calculated as the elapsed time from administration of Dose 1 to the administration of the first dose of rescue analgesia.
Patient Global Assessment (PGA) of Pain Control0 hour to 48 hours after IP administrationPGA of pain control was evaluated by subject reported degree of pain control according to a 5 point scale (0-4)
Time to First Dose of Rescue Analgesia0 hour to 48 hours after IP administrationTime to first rescue was calculated as the elapsed time from administration of Dose 1 to the administration of the first dose of rescue analgesia.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026